Expres2ion Biotech Holding Stock Current Asset
EXPRS2 Stock | SEK 2.74 0.09 3.18% |
ExpreS2ion Biotech Holding fundamentals help investors to digest information that contributes to ExpreS2ion Biotech's financial success or failures. It also enables traders to predict the movement of ExpreS2ion Stock. The fundamental analysis module provides a way to measure ExpreS2ion Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ExpreS2ion Biotech stock.
ExpreS2ion |
ExpreS2ion Biotech Holding Company Current Asset Analysis
ExpreS2ion Biotech's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition |
In accordance with the recently published financial statements, ExpreS2ion Biotech Holding has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current asset for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
All Next | Launch Module |
ExpreS2ion Fundamentals
Return On Equity | -0.97 | |||
Return On Asset | -0.55 | |||
Operating Margin | (20.75) % | |||
Current Valuation | 361.15 M | |||
Shares Outstanding | 37.15 M | |||
Shares Owned By Institutions | 1.75 % | |||
Price To Book | 3.42 X | |||
Price To Sales | 55.94 X | |||
Revenue | 12.23 M | |||
Gross Profit | 1.07 M | |||
EBITDA | (45.5 M) | |||
Net Income | (43.92 M) | |||
Cash And Equivalents | 10.14 M | |||
Cash Per Share | 0.75 X | |||
Total Debt | 3.48 M | |||
Debt To Equity | 10.40 % | |||
Current Ratio | 2.62 X | |||
Book Value Per Share | 2.75 X | |||
Cash Flow From Operations | (45.65 M) | |||
Earnings Per Share | (1.55) X | |||
Number Of Employees | 14 | |||
Beta | 1.25 | |||
Market Capitalization | 487.85 M | |||
Total Asset | 151.96 M | |||
Z Score | 84.0 | |||
Net Asset | 151.96 M |
About ExpreS2ion Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ExpreS2ion Biotech Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ExpreS2ion Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ExpreS2ion Biotech Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ExpreS2ion Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ExpreS2ion Biotech's short interest history, or implied volatility extrapolated from ExpreS2ion Biotech options trading.
Pair Trading with ExpreS2ion Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ExpreS2ion Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ExpreS2ion Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with ExpreS2ion Stock
0.76 | GENO | Genovis AB | PairCorr |
0.7 | HNSA | Hansa Biopharma AB | PairCorr |
Moving against ExpreS2ion Stock
0.73 | EGTX | Egetis Therapeutics Earnings Call This Week | PairCorr |
0.72 | PIERCE | Pierce Group AB | PairCorr |
0.71 | EPRO-B | Electrolux Professional | PairCorr |
0.65 | THULE | Thule Group AB | PairCorr |
0.64 | KAR | Karnov Group AB | PairCorr |
The ability to find closely correlated positions to ExpreS2ion Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ExpreS2ion Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ExpreS2ion Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ExpreS2ion Biotech Holding to buy it.
The correlation of ExpreS2ion Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ExpreS2ion Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ExpreS2ion Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ExpreS2ion Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ExpreS2ion Biotech Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for ExpreS2ion Stock analysis
When running ExpreS2ion Biotech's price analysis, check to measure ExpreS2ion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ExpreS2ion Biotech is operating at the current time. Most of ExpreS2ion Biotech's value examination focuses on studying past and present price action to predict the probability of ExpreS2ion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ExpreS2ion Biotech's price. Additionally, you may evaluate how the addition of ExpreS2ion Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |